CMRX Logo

Chimerix, Inc. (CMRX) 

NASDAQ
Market Cap
$277M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
611 of 963
Rank in Industry
335 of 552

Largest Insider Buys in Sector

CMRX Stock Price History Chart

CMRX Stock Performance

About Chimerix, Inc.

Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs include ONC201 a program for treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients; ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist that demonstrated enhanced non-competitive DRD2 antagonism relative to ONC201, which is in Phase I clinical trials to treat solid tumors; ONC212, an imipridone agonist of the orphan G protein-coupled receptors (GPCR) tumor suppressor GPR132, as well as ClpP for solid tumors and hematological malignancies, including pancreatic cancer and leukemias; and dociparstat sodium (DSTAT), which inhibits the activities of key proteins implicated in the resistance of acute myeloid leukemia blasts and leukemic stem cells to chemotherapy. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; and SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.

Insider Activity of Chimerix, Inc.

Over the last 12 months, insiders at Chimerix, Inc. have bought $0 and sold $7,673 worth of Chimerix, Inc. stock.

On average, over the past 5 years, insiders at Chimerix, Inc. have bought $174,564 and sold $7.53M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 17,295 shares for transaction amount of $16,522 was made by MIDDLETON FRED A (director) on 2023‑11‑17.

List of Insider Buy and Sell Transactions, Chimerix, Inc.

2024-08-08SalePRESIDENT AND CEO
1,285
0.0014%
$0.83$1,065+7.50%
2024-02-14SalePRESIDENT AND CEO
1,744
0.0019%
$1.04$1,809-10.95%
2024-02-14SaleVP OF FINANCE AND ACCOUNTING
2,660
0.003%
$1.04$2,777-10.95%
2024-02-14SaleCHIEF FINANCIAL OFFICER
1,940
0.0022%
$1.04$2,023-10.95%
2023-11-17Purchasedirector
17,295
0.0192%
$0.96$16,522-1.34%
2023-11-10Purchasedirector
2,705
0.003%
$0.92$2,489+0.63%
2023-09-28SaleVP of Finance and Accounting
3,610
0.0042%
$0.99$3,584-1.44%
2023-09-25Purchasedirector
20,000
0.0226%
$0.98$19,636-2.43%
2023-05-18PurchaseChief Business Officer and CFO
51,700
0.0598%
$1.14$59,150-10.71%
2023-05-12PurchaseChief Executive Officer
87,000
0.0987%
$1.12$97,652-9.82%
2023-05-10Purchasedirector
18,000
0.02%
$1.11$19,980-10.62%
2023-05-08Purchasedirector
8,750
0.0101%
$1.14$9,975-9.82%
2023-03-28Purchasedirector
20,000
0.023%
$1.21$24,152-10.92%
2023-01-26SalePrincipal Accounting Officer
3,230
0.0036%
$1.76$5,686-36.80%
2022-09-29SalePrincipal Accounting Officer
4,400
0.005%
$1.86$8,185-24.86%
2022-09-29Purchase
20,000
0.0229%
$1.86$37,176-24.86%
2022-05-19Purchase
1,419
0.0015%
$2.05$2,909-16.36%
2022-05-19Purchase
20,000
0.0212%
$2.04$40,738-16.36%
2022-05-17PurchaseChief Business Officer and CFO
15,000
0.0168%
$1.71$25,635+5.14%
2022-05-17Purchase
10,000
0.0105%
$1.61$16,100+5.14%

Insider Historical Profitability

22.85%
Andriole Michael T.PRESIDENT AND CEO
462453
0.5142%
$3.0842+44.13%
Jakeman DavidVP OF FINANCE AND ACCOUNTING
141232
0.157%
$3.08010
LaSpaluto MichelleCHIEF FINANCIAL OFFICER
110999
0.1234%
$3.0801
CANTEX PHARMACEUTICALS, INC.10 percent owner
3500000
3.8917%
$3.0801
Canaan VII L P
2584990
2.8743%
$3.0801
Hutton Wende S
2584990
2.8743%
$3.0801
New Leaf Ventures II, L.P.director
2243394
2.4944%
$3.0801
CHAMPSI FARAHdirector
1714330
1.9062%
$3.0801
NIEDEL JAMESdirector
1046082
1.1631%
$3.0804
Sanderling Venture Partners V, LP10 percent owner
993646
1.1048%
$3.0801
PAPPAS ARTHUR Mdirector
830695
0.9237%
$3.0801
Sanderling Venture Partners VI Co Investment Fund LP10 percent owner
697346
0.7754%
$3.0802
Nichols GarrettChief Medical Officer
260066
0.2892%
$3.0803
MARIO ERNESTdirector
108167
0.1203%
$3.08199+22.4%
MIDDLETON FRED Adirector
100000
0.1112%
$3.08120+17.74%
Berrey M MichellePresident and CEO
99685
0.1108%
$3.0850+24.59%
Sherman Michael A.Chief Executive Officer
87000
0.0967%
$3.0830+23.84%
DEMSKI MARTHA Jdirector
72055
0.0801%
$3.08416<0.0001%
Richardson Linda MChief Commercial Officer
60996
0.0678%
$3.0801
Meyer Robert J.director
35150
0.0391%
$3.0850+34.82%
WOLLAEGER TIMOTHYdirector
10000
0.0111%
$3.0813<0.0001%
Machado Clarence Patrickdirector
10000
0.0111%
$3.0810<0.0001%
Trost Timothy W.SVP, CFO & Secretary
9850
0.011%
$3.08014
DRAKE RODMAN Ldirector
3500
0.0039%
$3.0850+42.2%
Ricciardi Lisadirector
1950
0.0022%
$3.0810
MOCH KENNETH IPresident and CEO
1313
0.0015%
$3.0804
LEONARD JOHN M.director
0
0%
$3.0821+38.28%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
RA Capital Management, L.P.$9.33M9.828.8M0%+$00.01
Monaco Asset Management Sam$4.64M4.884.38M0%+$02.13
The Vanguard Group$4.61M4.854.35M0%+$0<0.0001
Armistice Capital Llc$2.4M2.532.26M-12.86%-$354,040.000.01
Acadian Asset Management$2.3M2.432.17M+15.51%+$309,325.090.01
Citadel Advisors LLC$2.01M2.111.9M-8.11%-$177,404.76<0.01
Renaissance Technologies$1.97M2.071.85M+18.68%+$309,307.45<0.01
Goldman Sachs$1.23M1.291.16M-1.7%-$21,255.12<0.0001
Millennium Management LLC$1.16M1.221.09M+0.31%+$3,531.92<0.01
Bridgeway Capital Management$1.15M1.211.08M+4.81%+$52,575.980.02
BlackRock$1.08M1.131.01M-3.06%-$33,885.02<0.0001
Geode Capital Management$1.03M1.09972,799+6.58%+$63,655.11<0.0001
Acuitas Investments, LLC$673,377.000.71635,261+100.66%+$337,800.970.36
Northern Trust$591,995.000.62558,486-19.1%-$139,740.82<0.0001
Yakira Capital Management Inc$538,892.000.57508,3890%+$00.03
Assenagon Asset Management S.A.$481,736.000.51454,468-9%-$47,618.37<0.01
Tejara Capital Ltd$439,296.000.46414,430-24.66%-$143,784.830.15
Adage Capital Partners Gp L L C$424,000.000.45400,0000%+$0<0.01
BNY Mellon$411,831.000.43388,520-8.69%-$39,201.96<0.0001
D. E. Shaw & Co.$397,104.000.42374,626+37.95%+$109,240.54<0.0001
Barclays$347,000.000.37327,356-63.29%-$598,219.79<0.0001
State Street$312,467.000.33294,780-2.71%-$8,692.01<0.0001
Shay Capital Llc$253,220.000.27238,887+0.36%+$915.840.04
Connor Clark & Lunn Investment Management Ltd$209,930.000.22198,047-9.39%-$21,759.70<0.0001
Tealwood Asset Management$122,970.000.13116,009+24.34%+$24,071.630.03
Pale Fire Capital Se$111,084.000.12104,796-50.38%-$112,803.32<0.01
Credit Suisse$99,640.000.1194,000-29.85%-$42,400.00<0.0001
Verition Fund Management Llc$84,800.000.0980,0000%+$0<0.01
Ci Private Wealth Llc$76,379.000.0872,0550%+$0<0.0001
Vontobel Holding Ltd$74,200.000.0870,0000%+$0<0.01
Morgan Stanley$72,292.000.0868,199-82.22%-$334,397.80<0.0001
Royal Bank of Canada$56,000.000.0652,400-37.81%-$34,049.92<0.0001
Two Sigma$52,058.000.0649,111+334.61%+$40,079.92<0.0001
Vance Wealth Inc$50,159.000.0547,3200%+$00.03
Susquehanna International Group$49,470.000.0546,670+35.43%+$12,941.49<0.0001
Raymond James Associates$45,792.000.0543,2000%+$0<0.0001
Prelude Capital$43,884.000.0541,400New+$43,884.00<0.01
Koshinski Asset Management Inc$107,200.000.0540,000New+$107,200.000.01
Point72 Asia Singapore Pte Ltd$39,121.000.0436,907New+$39,121.00<0.01
Xtx Topco Ltd$38,061.000.0435,907-56.7%-$49,840.65<0.01
StoneRidge Investment Partners LLC$38,000.000.0436,171New+$38,000.000.01
Joel Isaacson & Co., LLC$35,662.000.0433,6430%+$0<0.01
Russell Investments Group Ltd$34,556.000.0432,6000%+$0<0.0001
Fidelity Investments$31,229.000.0329,461-40.65%-$21,384.67<0.0001
UBS$29,935.000.0328,241-36.33%-$17,081.64<0.0001
Two Sigma Advisers LP$28,620.000.0327,000+21.08%+$4,982.00<0.0001
Toroso Investments Llc$24,249.000.0322,876New+$24,249.00<0.0001
Simplex Trading Llc$22,000.000.0221,638+90.16%+$10,430.63<0.01
Wells Fargo$20,547.000.0219,384+2,900.62%+$19,862.24<0.0001
Jane Street Capital$18,864.000.0217,796-90.89%-$188,160.87<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.